NEW YORK—Early plasma in massive hemorrhage of critically injured patients could have an actual mortality benefit.
“Over the period between 2012 and 2016, trauma research came to the pretty firm conclusions that not only was the historical approach of high levels of crystalloid resuscitation bad, but that early administration of blood products in severely injured bleeding trauma patients is quite good for them,” said James Littlejohn, MD, PhD, an associate professor of